StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Impact BioMedical

Impact BioMedical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Impact BioMedical figures

See a number that looks wrong?